Trademarkia Logo

Canada

C$
IMMUNO-ARCHITECT
REGISTERED

on 5 Sept 2019

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

Route 206 & Province Line RoadPrinceton, NJ 08543

US

Serial Number

1804484 filed on 13th Oct 2016

Registration Number

TMA1052838 registered on 5th Sept 2019

Registration expiry Date

5th Sept 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

IMMUNO-ARCHITECT

Trademark usage description

printed matter, namely, booklets, brochures, pamphlets and newsletters on the subject of pharmaceuticals and healthcare training courses for employee Read More

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents


Classification kind code

10

Class [016]
Printed matter, namely, booklets, brochures, pamphlets and newsletters on the subject of pharmaceuticals and healthcare


Classification kind code

10

Class [041]
Training courses for employees to develop leadership skills in the field of pharmaceuticals and healthcare scientific research


Classification kind code

10

Class [044]
Providing health information to physicians, health care professionals and patients in the field of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, immunotherapies for the treatment of cancer, hyperlipidemia, insulin resistance, metabolic syndrome, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, pharmaceutical antibodies for use as anti-infectives and for use as anti-inflammatories, diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents


Classification kind code

10

Mark Details


Serial Number

1804484

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 16th Aug 2018
Approved
Submitted for opposition 27
on 29th Jun 2018
Approval Notice Sent
Submitted for opposition 23
on 29th Jun 2018
Default Removed
Submitted for opposition 14
on 19th Jun 2018
Default Notice Sent
Submitted for opposition 12
on 5th Dec 2017
Extension of Time
Submitted for opposition 22
on 29th May 2017
Search Recorded
Submitted for opposition 20
on 29th May 2017
Examiner's First Report
Submitted for opposition 31
on 17th Oct 2016
Formalized
Submitted for opposition 30
on 13th Oct 2016
Filed
Submitted for opposition 1
on 13th Oct 2016
Created